Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Añadir filtros








Intervalo de año
1.
Cancer Research and Clinic ; (6): 464-468, 2021.
Artículo en Chino | WPRIM | ID: wpr-912906

RESUMEN

Conventional magnetic resonance imaging (MRI) is often used to evaluate the therapeutic effect of nasopharyngeal carcinoma. Single conventional MRI can only evaluate the change of tumor size and cannot accurately predict the curative effect of tumors. Functional imaging technology can further supplement the information of curative effect prediction. However, single imaging evaluation has some limitations in the evaluation of tumor efficacy. The combination of functional imaging and biomarkers for the evaluation and prediction of curative effect may provide a new choice for the evaluation model of nasopharyngeal carcinoma. This paper reviews the progress of current status of therapeutic evaluation models for nasopharyngeal carcinoma, functional imaging technology and single or joint evaluation model of biomarkers, so as to provide ideas for the efficacy evaluation model for nasopharyngeal carcinoma which is accurate and easy to be promoted and applied.

2.
Chinese Journal of Clinical Oncology ; (24): 438-441, 2016.
Artículo en Chino | WPRIM | ID: wpr-490332

RESUMEN

Objective:To compare the adverse reactions of concurrent chemoradiotherapy with docetaxel versus those of sequential and scheduled adjuvant therapy after a modified radical mastectomy in locally advanced breast cancer. Additionally, this work aims to evaluate the safety and feasibility of a synchronous therapy schedule. Methods:A total of 155 female breast cancer patients in the Fourth Affiliated Hospital of Guangxi Medical University were enrol ed from January 2009 to December 2014. Al the patients were diagnosed with infiltrating ductal carcinoma and stage pT3-4, pN1-3c M0, or pAnyTpN2-3cM0 after modified radical mastectomy. After completing the fluorouracil+epirubicin+cyclophosphamide adjuvant chemotherapy, all the patients were randomly divided into two groups by using the method of sealed envelopes. The synchronous group, which received synchronous chemoradiotherapy with docetaxel, comprised 78 cases. The sequential group, which received radiotherapy fol owing docetaxel chemotherapy, comprised 77 cases. The clinical toxic reactions and effects in both groups were assessed after all schedules. Results:A median follow-up period of 39 (16-62) months showed that the radiation side effects of the synchronous and sequential groups were mild. No patients with 3-4 grade radiation-induced skin reactions or symptoms of heart and lung radiation side effects were reported. The rate of 1-2 grade radiation-induced skin reactions was 89.7%(70/78) in the synchronous group and 88.3%(68/77) in the sequential group, but the difference was not statistically significant (P>0.05). The three-year recurrence-free survival rate was 92.3%(72/78) in the synchronous group and 81.8%(63/77) in the sequential group, and the difference was statistically significant (P=0.046). Conclusion:Synchronous chemoradiotherapy with docetaxel as adjuvant therapy exhibited mild and tolerable adverse reactions fol owing modified radical mastectomy in local y advanced breast cancer. Compared with the sequential schedule, the synchronous schedule showed a significantly increased three-year recurrence-free survival rate. Therefore, a synchronous chemo-radiotherapy schedule is safe and feasible and can be used as a treatment option for locally advanced breast cancer.

3.
Cancer Research and Clinic ; (6): 738-741, 2012.
Artículo en Chino | WPRIM | ID: wpr-429517

RESUMEN

Objective To detect the ERCC1 expression in nasopharyngeal cancer(NPC),to analyze its relationship with concurrent chemo-radiotherapy.Methods The biopsy specimens were obtained through nasopharyngeal endoscopy from patients with NPC in the Fourth Affiliated Hospital of Guangxi Medical University from January 2008 to December 2008.The ERCC1 expression in the cancer tissue was detected using MaxVision immunohistochemistry.Eight weeks after the chemo-radiotherapy,MRI was performed,The MRI results were used to assess the efficacy according to RECIST 1.1 standard,with sensitive group including complete relief (CR) and partial relief (PR) and insensitive group including stable disease(SD) and progress disease (PD).MRI was re-performed every three months with follow-up 3 years.The relationships between ERCC1 expression and concuTent chemo-radiotherapy in the short-term sensitivity and overall survival in patients with nasopharyngeal cancer were analyzed.Results 76 cases were collected.All cases were evaluable for the short-term sensitivity,and only 72 cases were evaluable for progression-free rate and overall survival (OS).In 76 short-term curative effect evaluable cases,CR was 56 cases (73.68 %),PR was 11 cases (14.47 %),SD was 3 cases (3.95 %),PD was 6 cases (7.89 %),respectively.RR (effective efficiency) was 88.16 % and DCR (disease control rate) was 92.1%.The positive rate of ERCC1 expression was 42.1% (32/76),with 37.3 % (24/67) in the sensitive group (CR+PR) and 88.8 % (8/9) in the non-sensitive group (SD+PD).RR and DCR in the negative ERCC1 expression group were higher (97.7 %,97.7 %) than those in the positive expression group (75 %,81.3 %,x2 =7.119,P < 0.05).Of 72 case,twelve month progression-free survival (PFS) rate was 91.7 % (66/72),with 95.5 % (39/41) in the negative ERCC1 expression group and 87.1% (27/31) in the ERCC 1 positive group,and there was no significant difference between the 2 groups (x 2 =0,623,P =0.430).Of 72 cases,one year OS rate was 93.0 % (67/72),two years OS rate was 84.7 % (61/72),three years OS rate was 72.2 %(52/72).Of 31 ERCC1 positive cases one year OS rate was 90.6 %(28/31),two years OS rate was 77.4 % (27/31),and three years OS rate was 61.3 % (19/31).Of 41 ERCC1 negative eases one year OS rate was 95.5 %(39/41),two years OS rate was 90.2 % (37/41),and three years OS rate was 82.9 % (34/41).The ERCC1 expression demonstrated significant correlation with the short-term sensitivity and OS (x2 =4.192,P =0.041).Conclusion The ERCC1 expression in NPC has negative correlation with the chemo-radiotherapy and short-term sensitivity,which may predict the chemo-radio therapy sensitivity in NPC.The ERCC1 expression in NPC has significant correlation with OS.It may predict the prognosis of NPC.

4.
Chinese Journal of Radiation Oncology ; (6): 435-437, 2009.
Artículo en Chino | WPRIM | ID: wpr-392443

RESUMEN

Objective To study the effect of scan position consistency on computer tomography-magnetic resonance (CT-MR) images automatic registration in patients with nasopharyngeal carcinoma.Methods Fifteen patients with nasopharyngeal carcinoma were enrolled in this study and scanned with the same position to acquire CT images and MR-1 images. Then they were reacanned with different position for MR-2 images. Image registration of CT-MR-1 and CT-MR-2 was finished using mutual information method.The registration errors were evaluated by measuring the distances between marks. Results The error of au-tomatic CT-MR registration with consistent scan position was 1.32 nun, comparing with the minimum of 2.00 ram and the maximum of 3.83 mm with different positions. Conclusion Keeping consistent scan position can improve the accuracy of image registration.

5.
China Oncology ; (12)2006.
Artículo en Chino | WPRIM | ID: wpr-546805

RESUMEN

Background and purpose:It has been shown that chemotherapy could improve the quality of life and prolongation of survival time of the patients with advanced gastric cancer. There is still no standard chemotherapy regimen for advanced and metastatic gastric cancer, and regimens with high efficacy and safety are scare. Toxicities are considered to be limiting factors and in? uence the quality of life in the patients with advanced gastric cancer. The purpose of this study was to investigate the effi cacy and toxicity of docetaxel(DOC) in combination with oxaliplatin(OXA) as fi rst-line treatment in advanced gastric cancer and try to fi nd a regimen that would be more tolerable without deterioration of treatment response. Methods:48 patients with advanced gastric cancer were treated with docetaxel 35 mg/m2, ivgtt, d1,d8 combined with oxaliplatin 130 mg/ m2,ivgtt,d1 ;repeated every 3 weeks (one cycle) ,The effect was evaluated after two cycles. The effi cacy and toxicity were evaluated according to WHO standard. Results:48 patients could be evaluated for clinical response. Complete response in 3 pts and partial response in 24 pts were observed with an overall response rate of 56.25%, median time to progression (MTTP) was 5.6 months and median overall survival (MST) was 11.8 months. The most common toxicities were bone marrow suppression, peripheral neuritis, nausea and vomiting. All of them are reversible. Conclusion:Combining weekly docetaxel and oxaliplatin is an effective and well tolerated alternative treatment in advanced gastric cancer and has yielded promising results.

6.
China Oncology ; (12)2000.
Artículo en Chino | WPRIM | ID: wpr-545038

RESUMEN

0.05)。The median time to progression (mTTP)was 5.8 months in XELOX group and 5.7 months in FOLFOX4 group. The median survival time (MST) was 10.0 months in XELOX group and 9.8 months in FOLFOX4 group, The toxicities were well tolerated,The incidence of grade Ⅲ+Ⅳ nausea and vomiting was significantly lower in XELOX group than in FOLFOX4 group (P0.05).Conclusions:Both of the two regimens were feasible, well tolerated and effective in treatment of advanced gastric cancer。XELOX regimen may be safer than FOLFOX4 regimen,especially in elderly patients or patients with ECOG PS of 1 to 2.

7.
China Oncology ; (12)1998.
Artículo en Chino | WPRIM | ID: wpr-547388

RESUMEN

0.05).The median time to progression (mTTP) was 7.8 months in HCPTOX group and 7.9 months in FOLFOX4 group, respectively. The median survival time (MST) was 13.1 months in HCPTOX group and 13.3 months in FOLFOX4 group, respectively. The toxicities were well tolerated.The incidence of grade Ⅲ+Ⅳ nausea and vomiting was significantly lower in HCPTOX group than in FOLFOX4 group (?2=4.538,P0.05). Conclusion:Both of the two regimens were feasible, well tolerated and effective in treatment of metastatic colorectal cancer.HCPTOX regimen might be safer than FOLFOX4 regimen,especially in elderly patients or patients with ECOG PS of 1 to 2.

8.
Chinese Traditional Patent Medicine ; (12)1992.
Artículo en Chino | WPRIM | ID: wpr-577758

RESUMEN

AIM:To establish a method of determining the content of chlorogenic acid,paracetmol,vitamin C and chlorphenamine maleate in Vitamin C Yinqiao Tablets. METHODS: The separation was performed in the C_(18) colunm with the mobile phase of methanol-acetonitril-0.02% phosphate acid(5∶10∶85).The flow rate was(1.0 mL/min) with the wavelength at 219 nm and 310 nm,the temperature of column was 35 ℃. RESULTS: The calibration curves were linear in the ranges of 0.03-0.13 ?g for chlorogenic acid,0.94-4.68 ?g for paracetmol,0.49-2.44 ?g for Vitamin C,0.01-0.05 ?g for chlorphenamine maleate,the average recoveries were not less than 98%,respectively. CONCLUSION: The method is simple,rapid and with satisfactory results.It is suitable for quality control of Vitamin C Yinqiao Tablets.

9.
Chinese Traditional Patent Medicine ; (12)1992.
Artículo en Chino | WPRIM | ID: wpr-577538

RESUMEN

AIM:To establish the method of determining notoginsenoside R_1,ginsenoside Rg_1 and Rb_1 in Xinning Tablet(Radix et Rhizoma Salvae Miltiorrhizae,Radix et Rhizoma notoginseng,Flos Carthami,Rhizoma Chuanxiong,ect).METHODS:HPLC-ELSD was used to determine notoginsenoside R_1,ginsenoside Rg_1 and Rb_1 in Xinning Tablet.The separatrion was performed on C_ 18 colunm with acetonitrile and water being used as a gradient program at 35 ℃.The elution program was(0-5 min,20%-25% acetonitrile;5-20 min,25%-45% acetonitrile),drift tube temperature was at 70 ℃,gas flow rate of 2.0 L/min.RESULTS:3 saponins were separated well.Average recoveries were 102.32% for notoginsenoside R_1 100.73% for ginsenoside Rg_1;101.40% for ginsenoside Rb_1,respectively.CONCLUSION:The method is simple and rapid and with satisfactory results and is suitable for quality control of Xinning Tablet.

10.
Chinese Traditional Patent Medicine ; (12)1992.
Artículo en Chino | WPRIM | ID: wpr-571293

RESUMEN

Objective: To establish the quality standard for Yangyinjiangtang Tablet. (Radix Astragali, Cortex Moutan, Rhizoma Polygoni Cuspidati, Radix Puerariae, etc.). Methods: Radix Astragali, Radix Puerareiae, Cortex Moutan and Rhizoma Polygoni Cuspidatiwere by TLC. Puerarin was determined by HPLC. Results: Radix Astragali, Radix Puerareiae, Cortex Moutan and Rhizoma Polygoni Cuspidati could be detected by TLC. Puerarin showed a good linear relationship at a range of 10.0~60.0 ?g, r=0.9996. The average recovery was 99.6%, and RSD was 1.52%, respectively. Conclusion: The method established is simple, feasible and reproducible. This study provided a method for the quality control of Yangyinjiangtang Tablets.

11.
Chinese Traditional Patent Medicine ; (12)1992.
Artículo en Chino | WPRIM | ID: wpr-681723

RESUMEN

Objective: To perfect the quality standard of Fukeyangrong Pills and in order to control the quality of Fukeyangrong Pills. Methods:The qualitative and quantitative analyses were carried out by TLC and HPLC. Results: Radix anglicae sinesis; Radix ophiopognis, Radix pulsatillae and Radix scutellariae were idtentified successfully by TLC and the content of paeoniflorin in Fukeyangrong Pills was determined exactly by HPLC.Conclusion: The test provide scientific basis for the revision of the quality standard of Fukeyangrong Pills.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA